IMR Press / FBL / Volume 13 / Issue 12 / DOI: 10.2741/3022

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article

Regulation of neurite outgrowth by Gi/o signaling pathways

Show Less
1 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY 10029, USA
2 Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA

*Author to whom correspondence should be addressed.

 

Front. Biosci. (Landmark Ed) 2008, 13(12), 4544–4557; https://doi.org/10.2741/3022
Published: 1 May 2008
Abstract

Neurogenesis is a long and winding journey. A neural progenitor cell migrates long distances, differentiates by forming a single axon and multiple dendrites, undergoes maturation, and ultimately survives. The initial formation of neurites during neuronal differentiation, commonly referred to as "neurite outgrowth," can be induced by a large repertoire of signals that stimulate an array of receptors and downstream signaling pathways. The Gi/o family of heterotrimeric G-proteins are abundantly expressed in the brain and enriched at neuronal growth cones. Recent evidence has uncovered several Gi/o-coupled receptors that induce neurite outgrowth and has begun to elucidate the underlying molecular mechanisms. Emerging data suggests that signals from several Gi/o-coupled receptors converge at the transcription factor STAT3 to regulate neurite outgrowth and at Rac1 and Cdc42 to regulate cytoskeletal reorganization. Physiologically, signaling through Gi/o-coupled cannabinoid receptors is critical for proper central nervous system development. As the mechanisms by which Gi/o-coupled receptors regulate neurite outgrowth are clarified, it is becoming evident that modulating signals from Gi/o and their receptors has great potential for the treatment of neurodegenerative diseases.

Share
Back to top